MIMEDX GROUP, INC. (MDXG)

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Address

1775 W OAK COMMONS COURT, NE
MARIETTA, GA 30062

Founded

1985

Number of Employees

895

Website

http://www.mimedx.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 $5,194 $29,451 - $53,401 - $1,473 $3,255 $5,128 $1,191 - $510 $12,450
Average Price $5.90 $8.90 - $11.76 - $3.43 $5.57 $10.03 $4.77 - $7.18 $9.42
# Shares Purchased 880,370 3,310,422 - 4,540,118 - 429,918 584,464 511,049 249,778 - 71,055 1,322,147
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date 1.7% -32.6% - -49.0% - 75.1% 7.7% -40.2% 25.8% - -16.5% -36.3%
S&P 500 Return to Date 181.9% 173.0% - 129.7% - 93.1% 74.8% 31.7% 37.3% - 7.4% 91.1%
Excess Total Return -180.2% -205.5% - -178.7% - -18.0% -67.1% -71.9% -11.4% - -23.9% -127.4%
Quartile Rank
Percentile Rank 31% 22% - 16% - 69% 33% 19% 67% - 17% 20%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
HADEN ALEXANDRA O

MIMEDX GROUP, INC.
AN2 Therapeutics, Inc.
MACROGENICS INC
Axogen, Inc.